Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis & HIV

End-stage liver disease is a concern for people with HIV and hepatitis B or C co-infection

News
7 April 2015
Harm reduction

Alert: Serbia is losing harm reduction

Editor's pick
Eurasian Harm Reduction Network
2 April 2015
Diabetes

Cannabis use reduces risk of insulin resistance in people with HIV/HCV co-infection

News
2 April 2015
Hepatitis B

Oral hepatitis B vaccine could become a reality

Editor's pick
Medical Xpress
1 April 2015
Hepatitis C treatment

Cipla announces the launch of generic drug Sofosbuvir in India under the brand name ‘Hepcvir`

Editor's pick
Cipla press release
31 March 2015
Hepatitis C treatment

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C

Editor's pick
Gilead press release
31 March 2015
Hepatitis C transmission & prevention

HCV sexual transmission linked to anal sex, drug use, lower CD4 count

News
31 March 2015
Hepatitis C transmission & prevention

World first trials for hepatitis C wonder drug in Sydney's maximum security jails

Editor's pick
Sydney Morning Herald
30 March 2015
Access to healthcare

KEI Europe asks Romanian government to issue compulsory licences on hepatitis C medicines

Editor's pick
Knowledge Ecology International
23 March 2015
Access to healthcare

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

Editor's pick
MSF
19 March 2015
Access to healthcare

Gilead to require proof of citizenship to buy Sovaldi in poor countries

Editor's pick
Fierce Pharma
19 March 2015
Hepatitis C treatment

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Editor's pick
Motley Fool
18 March 2015
Hepatitis C treatment

Hepatitis C Drugs Will 'Strain Budgets': Study

Editor's pick
WebMD
17 March 2015
Hepatitis C treatment

Gilead's hepatitis C drugs largely cost-effective in US - study

Editor's pick
Reuters
17 March 2015
Hepatitis C treatment

Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir

News
17 March 2015
New & experimental hepatitis C treatment

FDA to review re-submitted Bristol-Myers hepatitis C drug

Editor's pick
Reuters
12 March 2015
Hepatitis B

WHO issues its first hepatitis B treatment guidelines

Editor's pick
World Health Organization
12 March 2015
Hepatitis C treatment

Hepatitis C pills drive surge in U.S. drug costs: report

Editor's pick
Reuters
12 March 2015
Hepatitis C treatment

Re-infection due to ongoing risk probably the cause of HCV recurrence after SVR

News
11 March 2015
Hepatitis C treatment

Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people

News
10 March 2015
Hepatitis C treatment

Here Is Why Gilead Sciences, Inc. Is Still Doing Better Than AbbVie Inc

Editor's pick
Bidness
10 March 2015
Access to healthcare

$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

Editor's pick
Bloomberg
9 March 2015
Access to healthcare

EECA CAB positions in regards to Janssen, BMS, Gilead and ViiV policy

Editor's pick
EATG
9 March 2015
Improving HIV care

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

Editor's pick
EurekAlert
9 March 2015